2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$5.50+$0.06 (+1.10%)
Price as of Jul 14, 2026 4:31 AM EDT- $349.3MMarket Cap
- -7.48%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$5.50+$0.06 (+1.10%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.44 | ||
Change | -$0.51 (-8.57%) | ||
Open | $5.94 | ||
High | $5.94 | ||
Low | $5.34 | ||
Previous Close | $5.95 | ||
Volume | 286,131 | ||
30-Day Average Volume | 397,145 | ||
1-Week Change | 7.72% | ||
1-Month Change | 30.14% | ||
1-Year Change | -7.48% | ||
3-Year Change | -31.57% | ||
5-Year Change | -42.13% | ||
Fundamentals | |||
Shares Outstanding | 58.7M | ||
Total Assets | $222.2M | ||
Market Cap | $349.3M | ||
Enterprise Value | $261.7M | ||
Period: QTR TTM FY | |||
Revenue | $3.3M | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$25.3M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $123.7M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 80 | ||
P/B | -5 | ||
P/E | -21 | ||
PEG | -1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue